@NewsWire_US Unsubstantiated rumors per usual - NPR better hope their βsourcesβ are right and not another case of TDS otherwise that lawsuit is gonna HURT
THROWBACK: Tylonel maker faced a class action lawsuit in 2023 over use of the drug during pregnancy being linked to birth disorders and autism.
The case was essentially ended because a federal judge blocked the evidence from being presented.